Laila Stærk

3.6k total citations · 3 hit papers
44 papers, 2.5k citations indexed

About

Laila Stærk is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Laila Stærk has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 15 papers in Internal Medicine and 4 papers in Epidemiology. Recurrent topics in Laila Stærk's work include Atrial Fibrillation Management and Outcomes (40 papers), Cardiac Arrhythmias and Treatments (21 papers) and Venous Thromboembolism Diagnosis and Management (15 papers). Laila Stærk is often cited by papers focused on Atrial Fibrillation Management and Outcomes (40 papers), Cardiac Arrhythmias and Treatments (21 papers) and Venous Thromboembolism Diagnosis and Management (15 papers). Laila Stærk collaborates with scholars based in Denmark, United States and United Kingdom. Laila Stærk's co-authors include Emelia J. Benjamin, Darae Ko, Robert Helm, Jason A. Sherer, Gunnar Gislason, Jonas Bjerring Olesen, Emil Loldrup Fosbøl, Christian Torp‐Pedersen, Gregory Y.H. Lip and Anders Nissen Bonde and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Laila Stærk

44 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atrial Fibrillation

2017 772 citations Laila Stærk, Jason A. Sherer et al. Circulation Research profile →
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study

2018 237 citations Laila Stærk, Biqi Wang et al. BMJ profile →
Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study

2024 36 citations Laila Stærk, Emelia J. Benjamin et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laila Stærk Denmark	23	2.2k	565	255	168	168	44	2.5k
Ken Okumura Japan	31	3.8k 1.7×	530 0.9×	353 1.4×	232 1.4×	222 1.3×	208	4.2k
Rasmus Havmoeller United States	4	3.0k 1.4×	365 0.6×	291 1.1×	175 1.0×	251 1.5×	4	3.3k
David Singh United States	6	3.0k 1.4×	366 0.6×	286 1.1×	171 1.0×	248 1.5×	35	3.3k
Chi‐Tai Kuo Taiwan	27	1.9k 0.9×	578 1.0×	255 1.0×	298 1.8×	186 1.1×	113	2.5k
Fa‐Po Chung Taiwan	29	2.6k 1.2×	392 0.7×	425 1.7×	124 0.7×	137 0.8×	182	2.9k
Jo‐Nan Liao Taiwan	31	2.7k 1.2×	496 0.9×	512 2.0×	137 0.8×	218 1.3×	176	3.1k
Lars Wallentin Sweden	20	1.8k 0.8×	619 1.1×	252 1.0×	183 1.1×	209 1.2×	47	2.2k
Mika Lehto Finland	19	1.6k 0.7×	218 0.4×	291 1.1×	158 0.9×	189 1.1×	103	1.9k
Eunsun Jang South Korea	26	1.8k 0.8×	221 0.4×	354 1.4×	106 0.6×	134 0.8×	82	2.1k
Michael Hanna United States	20	2.0k 0.9×	773 1.4×	293 1.1×	119 0.7×	160 1.0×	44	2.2k

Countries citing papers authored by Laila Stærk

Since Specialization

Citations

This map shows the geographic impact of Laila Stærk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laila Stærk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laila Stærk more than expected).

Fields of papers citing papers by Laila Stærk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laila Stærk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laila Stærk. The network helps show where Laila Stærk may publish in the future.

Co-authorship network of co-authors of Laila Stærk

This figure shows the co-authorship network connecting the top 25 collaborators of Laila Stærk. A scholar is included among the top collaborators of Laila Stærk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laila Stærk. Laila Stærk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blanche, Paul, Gregory Y.H. Lip, Anne‐Lise Kamper, et al.. (2024). Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation. European Heart Journal - Cardiovascular Pharmacotherapy. 10(3). 210–218. 3 indexed citations

Bonde, Anders Nissen, Torben Martinussen, Christina Ji‐Young Lee, et al.. (2020). Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes. 13(4). e006058–e006058. 14 indexed citations

Olsen, Anne‐Marie Schjerning, Patricia McGettigan, Thomas Alexander Gerds, et al.. (2019). Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. European Heart Journal - Cardiovascular Pharmacotherapy. 6(5). 292–300. 21 indexed citations

Olesen, Jonas Bjerring, et al.. (2019). Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants. Journal of the American College of Cardiology. 74(17). 2150–2158. 33 indexed citations

Stærk, Laila, Nicholas Carlson, Anne‐Lise Kamper, et al.. (2019). Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study. Thrombosis Journal. 17(1). 21–21. 17 indexed citations

Sindet‐Pedersen, Caroline, Morten Lamberts, Laila Stærk, et al.. (2018). Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease. Journal of the American College of Cardiology. 72(15). 1790–1800. 33 indexed citations

Bonde, Anders Nissen, Laila Stærk, Naja Emborg Vinding, et al.. (2018). Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control. Journal of the American College of Cardiology. 72(12). 1357–1365. 17 indexed citations

Stærk, Laila, Biqi Wang, Sarah R. Preis, et al.. (2018). Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 361. k1453–k1453. 237 indexed citations breakdown →

Bonde, Anders Nissen, Gregory Y.H. Lip, Anne‐Lise Kamper, et al.. (2017). Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries. Thrombosis and Haemostasis. 117(12). 2291–2299. 18 indexed citations

10.

Sindet‐Pedersen, Caroline, Jannik Langtved Pallisgaard, Laila Stærk, et al.. (2017). Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism. Thrombosis and Haemostasis. 117(6). 1182–1191. 31 indexed citations

11.

Stærk, Laila, et al.. (2017). Predicted risk of stroke and bleeding and use of oral anticoagulants in atrial fibrillation: Danish nationwide temporal trends 2011–2016. Thrombosis Research. 160. 19–26. 1 indexed citations

12.

Sindet‐Pedersen, Caroline, Jannik Langtved Pallisgaard, Laila Stærk, et al.. (2017). Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study. Scientific Reports. 7(1). 3347–3347. 32 indexed citations

13.

Stærk, Laila, Jason A. Sherer, Darae Ko, Emelia J. Benjamin, & Robert Helm. (2017). Atrial Fibrillation. Circulation Research. 120(9). 1501–1517. 772 indexed citations breakdown →

14.

Stærk, Laila, Emil Loldrup Fosbøl, Kasper Gadsbøll, et al.. (2016). Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark. Scientific Reports. 6(1). 31477–31477. 73 indexed citations

15.

Pallisgaard, Jannik Langtved, Tommi Bo Lindhardt, Laila Stærk, et al.. (2016). Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 3(3). pvw036–pvw036. 36 indexed citations

16.

Stærk, Laila, Emil Loldrup Fosbøl, Gregory Y.H. Lip, et al.. (2016). Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. European Heart Journal. 38(12). ehw496–ehw496. 74 indexed citations

17.

Pallisgaard, Jannik Langtved, Gunnar Gislason, Christian Torp‐Pedersen, et al.. (2016). Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation. PLoS ONE. 11(8). e0161768–e0161768. 2 indexed citations

18.

Stærk, Laila, Gunnar Gislason, Gregory Y.H. Lip, et al.. (2015). Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. EP Europace. 17(8). 1215–1222. 25 indexed citations

19.

Stærk, Laila, Gregory Y.H. Lip, Jonas Bjerring Olesen, et al.. (2015). Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ. 351. h5876–h5876. 101 indexed citations

20.

Pallisgaard, Jannik Langtved, Tommi Bo Lindhardt, Morten Lock Hansen, et al.. (2015). Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study. PLoS ONE. 10(10). e0141377–e0141377. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact